| Date | Filer | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|
| Nov 19, 2021 |
Chief Financial Officer
Trans History: 9
|
Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 22,500 | $0.56 | 55,500 |
| Nov 19, 2021 |
Chief Financial Officer
Trans History: 9
|
Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 22,500 | -- | 177,500 |
| Aug 17, 2021 |
Director
Trans History: 13
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 5
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 8
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 5
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 11
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Aug 17, 2021 |
Director
Trans History: 5
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,751 | -- | 40,751 |
| Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Jun 15, 2021 |
Chief Business Officer
Trans History: 2
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 400,000 | -- | 400,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.